🇺🇸 FDA
Patent

US 10981902

5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor

granted A61PA61P25/00

Quick answer

US patent 10981902 (5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor) held by Merck MSD (R&D) China Co., LTD. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Merck MSD (R&D) China Co., LTD.
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/00